S. Velamakanni

Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study

D. Boulware, Darlisha A Williams, D. Meya, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study

D. Boulware, K. H. Hullsiek, Darlisha A Williams, 2016, The Lancet. Infectious diseases.

The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2021, Wellcome Open Research.

Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus

D. Boulware, J. Rhein, A. Musubire, 2014, Medical mycology case reports.

Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.

S. Lofgren, D. Boulware, K. H. Hullsiek, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts

S. Lofgren, D. Boulware, K. H. Hullsiek, 2018, The Journal of infectious diseases.

A secondary analysis of depression outcomes from a randomized controlled trial of adjunctive sertraline for HIV-associated cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2022, Wellcome Open Research.

Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis

S. Lofgren, D. Boulware, K. H. Hullsiek, 2017, The Journal of infectious diseases.

SEVERE RESISTANT HYPOMAGNESEMIA AS THE FIRST CLINICAL PRESENTATION OF 17Q12 MICRODELETION SYNDROME

K. Gonuguntla, S. Velamakanni, N. Perosevic, 2020 .